Inflammatory markers such as CRP and D-dimer, along with immune response indicators (anti-RBD IgG and IgM), exhibited particularly strong associations with severe ARDS cases, aligning with established clinical patterns of COVID-19. The gene discussed is CD40LG; the disease is COVID-19.